Blocking the Integrin-αV/β5 dimer, either via gene deletion or with blocking antibodies, ameliorates YAP-induced cytostasis in YAPoff cancers (1), similar to the effects of inhibiting Netrin-1/UNC5 activity (Figs. 2C and 4A–D). Here, NTN1 is linked to cancer.